Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 638,922
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $60,375,372
Total People Sold 5 5 6 8
Total Sell Transactions 11 15 24 57
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1281
  Page 16 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lewis Alan Director   –       •      –    2012-11-07 4 OE $17.33 $259,950 D/D 15,000 30,900     -
   Heron Elaine J Director   –       •      –    2012-11-07 4 S $46.44 $4,876,116 D/D (105,000) 45,900     -
   Heron Elaine J Director   –       •      –    2012-11-07 4 OE $7.46 $1,726,350 D/D 105,000 150,900     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-11-05 4 AS $46.00 $2,840,000 D/D (60,000) 100,413     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-11-05 4 OE $17.33 $1,045,212 D/D 60,000 126,183     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-11-05 4 AS $46.00 $460,000 D/D (10,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-11-05 4 OE $11.05 $110,500 D/D 10,000 62,277     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-11-05 4 AS $46.00 $376,250 D/D (8,000) 15,340     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-11-05 4 OE $14.39 $115,120 D/D 8,000 23,340     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-11-02 4 GA $0.00 $0 I/I 161 5,563     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-11-02 4 GD $0.00 $0 D/D 161 55,025     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-11-01 4 AS $37.08 $185,384 D/D (5,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-11-01 4 OE $11.05 $55,250 D/D 5,000 57,277     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-10-31 5 B $21.76 $3,503 D/D 161 100,574     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-10-31 5 B $21.76 $11,924 D/D 548 15,294     -
   Wood Mark VP, Human Resources   •       –      –    2012-10-31 5 B $27.91 $16,408 D/D 588 23,245     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2012-10-31 4 A $21.76 $5,766 D/D 265 10,835     -
   Davis George Eric SVP, General Counsel   •       –      –    2012-10-31 4 A $21.76 $2,372 D/D 109 52,760     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-31 4 AS $37.68 $151,856 D/D (4,000) 174,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-31 4 OE $9.86 $29,580 D/D 3,000 178,691     -
   Bienaime Jean Jacques Chief Business Officer   •       •      –    2012-10-23 5 GA $0.00 $0 I/I 13,545 13,545     -
   Bienaime Jean Jacques Chief Business Officer   •       •      –    2012-10-23 5 GD $0.00 $0 D/D 13,545 135,901     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-22 4 AS $41.86 $125,578 D/D (3,000) 175,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-22 4 OE $9.86 $29,580 D/D 3,000 178,691     -
   Wood Mark VP, Human Resources   •       –      –    2012-10-22 4 AS $41.86 $111,554 D/D (2,665) 32,364     -
  1281 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 16 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us